Literature DB >> 2307544

Further characterization, isolation and identification of the epithelial cell-surface antigen defined by monoclonal antibody AUA1.

H Durbin1, N Rodrigues, W F Bodmer.   

Abstract

The human epithelial antigen recognized monoclonal antibody (MAb) AUA1 has been characterized as a cell-surface glycoprotein. It has been isolated from human colonic mucosa by AUA1 affinity separation. N-terminal peptide sequence of this purified material has revealed a 17 amino acid sequence which identifies it with one of a group of similar epithelial/tumor-associated glycoproteins defined by a variety of MAbs. Using the polymerase chain reaction to map the gene encoding this antigen, our previous AUA1 antigen assignment to chromosome 2 has been confirmed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307544     DOI: 10.1002/ijc.2910450331

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.

Authors:  E J Derbyshire; E J Wawrzynczak
Journal:  Br J Cancer Suppl       Date:  1991-06

2.  Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.

Authors:  J Zorzos; D V Skarlos; P Pozatzidou; A Zizi; A Bakiras; S Koritsiadis; D Pectasidis; P Koutsioumba; A A Epenetos; M Likourinas
Journal:  Urol Res       Date:  1994

Review 3.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

Authors:  Manon J Winter; Iris D Nagtegaal; J Han J M van Krieken; Sergey V Litvinov
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

4.  Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia.

Authors:  R Poulsom; M Pignatelli; W G Stetler-Stevenson; L A Liotta; P A Wright; R E Jeffery; J M Longcroft; L Rogers; G W Stamp
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

5.  Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.

Authors:  Chiara Nicolazzo; Isabella Massimi; Lavinia V Lotti; Simone Vespa; Cristina Raimondi; Fabio Maria Pulcinelli; Angela Gradilone; Paola Gazzaniga
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

6.  Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.

Authors:  E J Derbyshire; L de Leij; E J Wawrzynczak
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.